Association of baseline acetylcholine receptor antibody levels with efgartigimod treatment efficacy for patients with myasthenia gravis
Generalized MG patients with high baseline AChR antibody levels may exhibit a superior response to efgartigimod.
Authors
- Akiyuki Uzawa (ORCID: https://orcid.org/0000-0001-9252-1863)
- Satoshi Kuwabara (ORCID: https://orcid.org/0000-0002-4716-8578)
- Hiroyuki Akamine (ORCID: https://orcid.org/0000-0002-4041-1635)
- Kouichi Takasaka
- Yosuke Onishi
- Manato Yasuda (ORCID: https://orcid.org/0000-0002-2876-3857)
- Hideo Handa (ORCID: https://orcid.org/0000-0002-0787-4486)
- Kentaro Kurumada
- Etsuko Ogaya (ORCID: https://orcid.org/0009-0008-2716-6664)
Institutions
- Chiba University (JP)
- University of the Ryukyus (JP)
Publication Details
- Journal
- Journal of the Neurological Sciences
- Published
- 2025-10-30
- DOI
- https://doi.org/10.1016/j.jns.2025.123745
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00